Scientz Biotechnology Achieved Annual Operating Income Of 100 Million Yuan In 2018, A Year-on-year Increase Of 26.34%.

Memorabilia in 2018:

01. Established Ningbo Scientz Pharmaceutical Testing Technology Co., Ltd.

In order to expand the new product line, the company registered and established Ningbo Scientz Pharmaceutical Testing Technology Co., Ltd. in Ningbo, independent research and development, design, production and drug testing related equipment.

02. Established Ningbo Scientz International Trading Co., Ltd.

In response to the National One Belt and One Road initiative to better expand overseas business, the company officially established Ningbo Scientz International Trading Co., Ltd. in 2018, with the goal of making truly outstanding domestic laboratory equipment and equipment to serve the world.

03. Holding the company's 30th anniversary celebration

On August 18, 2018, the company held the theme of “Life Science Instrument Development Forum and SCIENTZ 30 Years Celebration” in Ningbo, and witnessed the company's 30 years of hard work with the friends from all walks of life, and looked forward to the future development opportunities.

04. Established Ningbo Scientz Biotechnology Co., Ltd. R&D and Innovation Hangzhou Branch

In order to better attract outstanding talents and realize the multi-innovation of the company's product line and business model, the company has invested heavily in setting up R&D and innovation centers in Binjiang District of Hangzhou. Hangzhou Research Center will attract outstanding talents in the industry, gather outstanding enterprises in the industry, and excellent equipment in production laboratories according to the requirements of high-quality talent echelon construction, high-standard product design concept and high-level strategic cooperation starting point, which will continue for the company for the next 30 years. Development provides motivation.

05. Complete the second employee equity incentive

In 2014, the company implemented the first employee equity incentive. By 2018, the employee shareholding ratio exceeded 15%. Through the establishment of multi-level compensation system, such as equity incentives, annual dividends, performance appraisal, etc., the company truly realizes the common growth of employees and the company and shares the benefits.